Posts

Showing posts with the label rare diseases
Show all
Image

Taking on the access hurdles for orphan drugs: preparing for EU HTA

Image

Finding new treatments for ALS patients: a look at the late-stage pipeline

Image

Turning Setbacks into Strategies: Lessons from RELYVIRO’s journey in ALS

Image

Breaking Barriers: TECELRA Becomes the First Engineered T-Cell Therapy for Solid Tumors

Image

Fabhalta: aprendizajes para el desarrollo exitoso de fármacos en enfermedades raras

Image

Fabhalta: learnings for successful drug development in rare diseases